Porton Pharma Solutions Ltd
SZSE:300363
Intrinsic Value
Porton Pharma Solutions Ltd. engages in the research and development and manufacture of pharmaceutical products and active pharmaceutical ingredients. [ Read More ]
The intrinsic value of one Porton Pharma Solutions Ltd stock under the Base Case scenario is 30.96 CNY. Compared to the current market price of 16.63 CNY, Porton Pharma Solutions Ltd is Undervalued by 46%.
Valuation Backtest
Porton Pharma Solutions Ltd
Run backtest to discover the historical profit from buying and selling Porton Pharma Solutions Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Porton Pharma Solutions Ltd
| Current Assets | 3.7B |
| Cash & Short-Term Investments | 2.1B |
| Receivables | 778.7m |
| Other Current Assets | 752.9m |
| Non-Current Assets | 5.4B |
| Long-Term Investments | 384.8m |
| PP&E | 3.9B |
| Intangibles | 601.8m |
| Other Non-Current Assets | 595.4m |
| Current Liabilities | 1.5B |
| Accounts Payable | 530.4m |
| Accrued Liabilities | 204.8m |
| Short-Term Debt | 310.1m |
| Other Current Liabilities | 485.4m |
| Non-Current Liabilities | 1.6B |
| Long-Term Debt | 1.1B |
| Other Non-Current Liabilities | 474.6m |
Earnings Waterfall
Porton Pharma Solutions Ltd
|
Revenue
|
4.9B
CNY
|
|
Cost of Revenue
|
-2.6B
CNY
|
|
Gross Profit
|
2.2B
CNY
|
|
Operating Expenses
|
-1.3B
CNY
|
|
Operating Income
|
929.3m
CNY
|
|
Other Expenses
|
-49.8m
CNY
|
|
Net Income
|
879.5m
CNY
|
Free Cash Flow Analysis
Porton Pharma Solutions Ltd
Profitability Score
Profitability Due Diligence
Porton Pharma Solutions Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
Score
Porton Pharma Solutions Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Porton Pharma Solutions Ltd's solvency score is 72/100. The higher the solvency score, the more solvent the company is.
Score
Porton Pharma Solutions Ltd's solvency score is 72/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Porton Pharma Solutions Ltd
According to Wall Street analysts, the average 1-year price target for Porton Pharma Solutions Ltd is 32.98 CNY with a low forecast of 24.24 CNY and a high forecast of 42 CNY.
Shareholder Return
Price
Porton Pharma Solutions Ltd
| Average Annual Return | 66.82% |
| Standard Deviation of Annual Returns | 88.03% |
| Max Drawdown | -84% |
| Market Capitalization | 8.9B CNY |
| Shares Outstanding | 534 408 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Porton Pharma Solutions Ltd. engages in the research and development and manufacture of pharmaceutical products and active pharmaceutical ingredients. The company is headquartered in Chongqing, Chongqing and currently employs 3,782 full-time employees. The company went IPO on 2014-01-29. The firm is also engaged in the multi-client product manufacturing businesses and pharmaceutical and chemical commerce businesses. The products of the Company include anti-viral, anti-diabetic, hypolipidemic, anti-cancer, anesthesia analgesia and anti-bacterial pharmaceuticals, among others. The firm operates its businesses in Europe, North America, Asia and China, among others.
Contact
IPO
Employees
Officers
The intrinsic value of one Porton Pharma Solutions Ltd stock under the Base Case scenario is 30.96 CNY.
Compared to the current market price of 16.63 CNY, Porton Pharma Solutions Ltd is Undervalued by 46%.
You don't have any saved screeners yet
